ZILBRYSQ ZILUCOPLAN
DEAD

Serial Number

88918443

Owner

Ra Pharmaceuticals, Inc.

Attorney

Jennifer Bryan

Filing Date

May 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZILBRYSQ ZILUCOPLAN Trademark

Serial Number: 88918443

ZILBRYSQ ZILUCOPLAN is a trademark filed by Ra Pharmaceuticals, Inc. on May 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Ra Pharmaceuticals, Inc. (10 trademarks)

Cambridge, MA 02140

Entity Type: 03

Trademark Details

Filing Date

May 15, 2020

Registration Date

Not Registered

Published for Opposition

September 29, 2020

Goods & Services

Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan

Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 28, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 28, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 24, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 29, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 29, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2020 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 1, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 1, 2020 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 25, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 25, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 25, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 25, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 24, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 19, 2020 PBCR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 4, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 4, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 4, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 4, 2020 CNEA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 22, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 8, 2020 PBCR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
ASSIGNED TO LIE
Jun 22, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2020 CNEA
ASSIGNED TO EXAMINER
Jun 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2020 NWOS
NEW APPLICATION ENTERED
May 19, 2020 NWAP